Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-02-11 17:40 |
VIVALIS ANNONCE LA TENUE DE SON ASSEMBLEE SPECIALE ET DE SON ASSEMBLEE GENERALE…
|
French | 77.3 KB | ||
| 2013-02-05 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE POUR L'UTILISA…
|
French | 70.9 KB | ||
| 2013-02-05 17:40 |
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE WITH THE ITALIAN ANIMA…
|
English | 85.9 KB | ||
| 2013-02-05 17:30 |
VIVALIS : ACTIONS ET DROIT DE VOTE JANVIER 2013
|
English | 132.7 KB | ||
| 2013-01-28 18:00 |
Intercell and Vivalis provide update on the progress towards intended merger
|
English | 52.4 KB | ||
| 2013-01-28 18:00 |
Point d'avancement sur le projet de fusion Intercell - Vivalis
|
French | 51.1 KB | ||
| 2013-01-24 08:30 |
VIVALIS : MISE A DISPOSITION DU DOCUMENT E RELATIF AU PROJET DE FUSION ENTRE …
|
English | 353.7 KB | ||
| 2013-01-15 17:40 |
AGENDA FINANCIER 2013 TRANSFERT DES ACTIONS VIVALIS AU COMPARTIMENT B D'EURONE…
|
French | 50.0 KB | ||
| 2013-01-15 17:40 |
2013 FINANCIAL CALENDAR VIVALIS SHARES TRANSFERRED TO COMPARTMENT B OF NYSE EUR…
|
English | 68.6 KB | ||
| 2013-01-03 17:46 |
VIVALIS : CONTRAT DE LIQUIDITE BILAN SEMESTRIEL
|
English | 207.9 KB | ||
| 2013-01-03 17:45 |
VIVALIS : ACTIONS ET DROIT DE VOTE DECEMBRE 2012
|
English | 133.9 KB | ||
| 2012-12-20 17:45 |
VIVALIS : RESULTAT DES VOTES ASSEMBLEE DES ACTIONNAIRES 12 DECEMBRE 2012
|
English | 81.1 KB | ||
| 2012-12-16 21:17 |
Proposed Merger of Equals between Vivalis and Intercell to Create Valneva
|
English | 52.8 KB | ||
| 2012-12-16 21:17 |
Proposition de fusion entre égaux entre Vivalis et Intercell pour former Valneva
|
French | 98.2 KB | ||
| 2012-12-10 17:45 |
VIVALIS :ACTIONS ET DROITS DE VOTE NOVEMBRE 2012
|
English | 134.0 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
